MA49506B1 - Synthèse d'omecamtiv mecarbil - Google Patents

Synthèse d'omecamtiv mecarbil

Info

Publication number
MA49506B1
MA49506B1 MA49506A MA49506A MA49506B1 MA 49506 B1 MA49506 B1 MA 49506B1 MA 49506 A MA49506 A MA 49506A MA 49506 A MA49506 A MA 49506A MA 49506 B1 MA49506 B1 MA 49506B1
Authority
MA
Morocco
Prior art keywords
synthesis
omecamtiv mecarbil
omecamtiv
mecarbil
relates
Prior art date
Application number
MA49506A
Other languages
English (en)
Inventor
Sebastien Caille
Fang Wang
Xianqing Shi
Kyle Quasdorf
Philipp Roosen
Andrew Cosbie
Zufan Wu
Archana Neergunda
Bin Quan
Lianxiu Guan
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Priority claimed from PCT/US2018/040176 external-priority patent/WO2019006231A1/fr
Publication of MA49506B1 publication Critical patent/MA49506B1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne une synthèse pour l'hydrate de dichlorhydrate d'omecamtiv mecarbil et divers intermédiaires. (i)
MA49506A 2017-06-30 2018-06-29 Synthèse d'omecamtiv mecarbil MA49506B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762527174P 2017-06-30 2017-06-30
PCT/US2018/040176 WO2019006231A1 (fr) 2017-06-30 2018-06-29 Synthèse d'omecamtiv mecarbil

Publications (1)

Publication Number Publication Date
MA49506B1 true MA49506B1 (fr) 2021-09-30

Family

ID=68382486

Family Applications (1)

Application Number Title Priority Date Filing Date
MA49506A MA49506B1 (fr) 2017-06-30 2018-06-29 Synthèse d'omecamtiv mecarbil

Country Status (2)

Country Link
AR (1) AR112220A1 (fr)
MA (1) MA49506B1 (fr)

Also Published As

Publication number Publication date
AR112220A1 (es) 2019-10-02

Similar Documents

Publication Publication Date Title
PH12020500655A1 (en) Compounds
MX2019011468A (es) Sintesis de inhibidor de mcl-1.
EA201891620A1 (ru) Ингибиторы взаимодействующей с рецептором протеинкиназы 1
MA40301B1 (fr) Composés indolecarboxamides utiles comme inhibiteurs de kinase
MY180083A (en) Tetrahydropyrrolothiazine compounds
EA201892430A1 (ru) Синтез индазолов
SG11201909186YA (en) Triazole silane compound, method for synthesizing said compound and use thereof
MX2021009594A (es) Sintesis de omecamtiv mecarbil.
MX2019011116A (es) Inhibidores de la tirosina quinasa de bruton.
EA202190475A1 (ru) Мини-gde для лечения гликогеноза iii типа
MX2023014281A (es) Lipidos novedosos.
PH12018500282A1 (en) Cgrp receptor antagonists
MA42776B1 (fr) Composés utiles pour l'inhibition du ror-gamma-t
PH12019500370A1 (en) Triazolopyrazinone derivative useful as a human pde1 inhibitor
MX2019008375A (es) Tiobenzoimidazol como fungicidas.
MY197202A (en) A liquid formulation of anti-tnf alpha antibody
MA39126A2 (fr) Synthèse d'enantiomère de progestérone et d'intermédiaires de celui-ci
ZA202004466B (en) Processes for the synthesis of sulfentrazone
MA39411A (fr) Synthèse de l'énantiomère de la progestérone et ses intermédiaires
MA49506B1 (fr) Synthèse d'omecamtiv mecarbil
MX2020006758A (es) Cemento de alumina.
MY188420A (en) Crystalline forms of (s)-afoxolaner
PH12017500492A1 (en) Crystalline bace inhibitors
PL411823A1 (pl) Ustnik do picia z puszki
MX2020010343A (es) Proceso para la purificacion de biocomposiciones complejas.